Skip to main content
TipRanks
Go Ultimate75% OFF

Acura Pharmaceuticals (ACUR) Ratios

85 Followers

Acura Pharmaceuticals Ratios

ACUR's free cash flow for Q4 2021 was $-426.00K. For the 2021 fiscal year, ACUR's free cash flow was increased by $0.00 and operating cash flow was $-426.00K. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 21Mar 21Dec 19Jun 19Dec 17
Liquidity Ratios
Current Ratio0.720.161.100.320.55
Quick Ratio0.720.161.100.320.55
Cash Ratio0.130.050.800.060.48
Solvency Ratio-1.16-0.14-0.48-0.62-1.16
Operating Cash Flow Ratio-1.44-0.10-0.58-2.72-0.97
Short-Term Operating Cash Flow Coverage-22.48-0.120.000.00-1.67
Net Current Asset Value$ -310.00K$ -6.45M$ -6.13M$ -5.31M$ -2.06M
Leverage Ratios
Debt-to-Assets Ratio0.233.612.341.960.59
Debt-to-Equity Ratio1.12-1.06-1.27-1.17-99.78
Debt-to-Capital Ratio0.5316.584.776.961.01
Long-Term Debt-to-Capital Ratio0.46-0.024.776.960.00
Financial Leverage Ratio4.83-0.29-0.54-0.59-170.52
Debt Service Coverage Ratio-2.53-0.10-6.58-8.02-1.46
Interest Coverage Ratio-6.07-1.68-1.57-9.91-8.77
Debt to Market Cap0.010.990.981.740.42
Interest Debt Per Share0.010.220.240.220.21
Net Debt to EBITDA-0.23-9.25-1.69-1.31-0.10
Profitability Margins
Gross Profit Margin94.24%99.94%99.92%99.57%95.68%
EBIT Margin-43.44%-21.23%-124.65%-840.73%-176.03%
EBITDA Margin-37.68%-17.73%-114.38%-772.44%-166.12%
Operating Profit Margin-77.67%-21.23%-27.29%-954.88%-176.16%
Pretax Profit Margin-56.24%-33.84%-142.04%-937.07%-196.12%
Net Profit Margin-56.24%-33.84%-142.04%-937.07%-191.57%
Continuous Operations Profit Margin-56.24%-33.84%-142.04%-937.07%-191.57%
Net Income Per EBT100.00%100.00%100.00%100.00%97.68%
EBT Per EBIT72.41%159.37%520.55%98.14%111.33%
Return on Assets (ROA)-102.21%-69.59%-147.31%-178.53%-123.41%
Return on Equity (ROE)-493.82%20.51%79.60%106.22%21044.44%
Return on Capital Employed (ROCE)-351.88%13.10%-48.72%-546.03%19351.85%
Return on Invested Capital (ROIC)-295.38%-200.53%-48.72%-546.03%-191.37%
Return on Tangible Assets-102.21%-72.64%-215.41%-338.50%-168.11%
Earnings Yield-4.00%-19.05%-61.41%-158.13%-88.47%
Efficiency Ratios
Receivables Turnover9.895.6913.702.0141.77
Payables Turnover0.4757.450.010.0042.67
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover3.577.384.920.684.37
Asset Turnover1.822.061.040.190.64
Working Capital Turnover Ratio-0.48-1.14-6.11-0.2716.57
Cash Conversion Cycle-741.7757.75-57451.75-125358.470.18
Days of Sales Outstanding36.9064.1126.65181.618.74
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding778.676.3557478.41125540.088.55
Operating Cycle36.9064.1126.65181.618.74
Cash Flow Ratios
Operating Cash Flow Per Share-0.02-0.02-0.02-0.18-0.28
Free Cash Flow Per Share-0.02-0.02-0.02-0.18-0.28
Dividend Paid and CapEx Coverage Ratio0.000.000.000.000.00
Capital Expenditure Coverage Ratio0.000.000.000.000.00
Operating Cash Flow Coverage Ratio-3.71-0.11-0.10-0.93-1.67
Operating Cash Flow to Sales Ratio-0.47-0.20-0.23-9.53-1.52
Free Cash Flow Yield-3.38%-11.34%-10.06%-160.84%-70.22%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-25.00-5.25-1.63-0.63-1.13
Price-to-Sales (P/S) Ratio14.061.782.315.932.17
Price-to-Book (P/B) Ratio123.46-1.08-1.30-0.67-237.87
Price-to-Free Cash Flow (P/FCF) Ratio-29.62-8.82-9.94-0.62-1.42
Price-to-Operating Cash Flow Ratio-29.62-8.82-9.94-0.62-1.42
Price-to-Earnings Growth (PEG) Ratio0.500.070.070.010.03
Enterprise Value Multiple-37.54-19.27-3.71-2.07-1.40
Enterprise Value22.11M12.20M11.28M6.56M6.90M
EV to EBITDA-37.54-19.27-3.71-2.07-1.40
EV to Sales14.153.424.2516.012.33
EV to Free Cash Flow-29.80-16.97-18.26-1.68-1.53
EV to Operating Cash Flow-29.80-16.97-18.26-1.68-1.53
Tangible Book Value Per Share0.00-0.20-0.21-0.22-0.08
Shareholders’ Equity Per Share0.00-0.20-0.18-0.17-0.00
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.02
Revenue Per Share0.040.120.100.020.19
Net Income Per Share-0.02-0.04-0.14-0.18-0.36
Tax Burden1.001.001.001.000.98
Interest Burden1.291.591.141.111.11
Research & Development to Revenue0.980.500.574.291.25
SG&A to Revenue0.800.710.716.260.00
Stock-Based Compensation to Revenue0.040.010.040.560.17
Income Quality0.840.600.161.020.79

Currency in USD